Inoue Yusuke, Nagahara Kazunori, Tanaka Yoshihito, Miyatake Hiroki, Hata Hirofumi, Hara Toshimasa
Department of Diagnostic Radiology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan; and
Department of Radiology, Kitasato University Hospital, Sagamihara, Japan.
J Nucl Med. 2015 May;56(5):695-700. doi: 10.2967/jnumed.114.153718. Epub 2015 Apr 3.
We evaluated the effective dose (ED) of the CT component of whole-body PET/CT using software dedicated to CT dose estimation and from dose-length product (DLP) values to establish practical methods of ED estimation.
Eighty adult patients who underwent (18)F-FDG whole-body PET/CT were divided into groups A and B, each consisting of 20 men and 20 women. In group A, ED of the CT component was calculated using CT-Expo for 6 anatomic regions separately, and whole-body ED was obtained by summing the regional EDs (CT-Expo method). DLP was calculated for each of the 6 regions and multiplied by a corresponding conversion factor described in International Commission on Radiological Protection publication 102 to obtain the ED for each region (regional DLP method). Whole-body ED was also calculated as the product of a whole-body DLP value provided by the scanner automatically and a conversion factor (simple DLP method). Moreover, the ED/DLP values were calculated using whole-body ED estimated by the CT-Expo method and the scanner-derived DLP, to optimize the conversion factor. In group B, the optimized conversion factor was applied for the estimation of ED by the simple DLP method.
In group A, the regional DLP method allowed an accurate estimation of mean whole-body ED as a result of counterbalance of mild overestimation in men and mild underestimation in women, regarding the CT-Expo method as a standard. The simple DLP method using a conversion factor for the trunk (0.015 mSv/mGy/cm) caused overestimation. On the basis of the ED/DLP values in group A, a modified conversion factor of 0.013 mSv/mGy/cm and sex-specific conversion factors of 0.012 and 0.014 mSv/mGy/cm for men and women, respectively, were determined. In group B, the use of the modified conversion factor improved accuracy, and the use of sex-specific conversion factors eliminated sex-dependent residual errors.
ED of the CT component of whole-body PET/CT can be assessed by multiplying the scanner-derived DLP by a conversion factor optimized for whole-body PET/CT.
我们使用专门用于CT剂量估算的软件,并根据剂量长度乘积(DLP)值评估了全身PET/CT中CT部分的有效剂量(ED),以建立ED估算的实用方法。
80例接受(18)F-FDG全身PET/CT检查的成年患者被分为A组和B组,每组各有20名男性和20名女性。在A组中,使用CT-Expo分别计算6个解剖区域的CT部分的ED,并通过将各区域ED相加得到全身ED(CT-Expo法)。计算6个区域中每个区域的DLP,并乘以国际放射防护委员会第102号出版物中描述的相应转换因子,以获得每个区域的ED(区域DLP法)。全身ED也通过将扫描仪自动提供的全身DLP值乘以一个转换因子来计算(简单DLP法)。此外,使用CT-Expo法估算的全身ED和扫描仪得出的DLP计算ED/DLP值,以优化转换因子。在B组中,将优化后的转换因子应用于通过简单DLP法估算ED。
在A组中,以CT-Expo法为标准,区域DLP法由于男性的轻度高估和女性的轻度低估相互抵消,能够准确估算平均全身ED。使用躯干转换因子(0.015 mSv/mGy/cm)的简单DLP法导致高估。根据A组的ED/DLP值,确定了修正转换因子为0.013 mSv/mGy/cm,男性和女性的性别特异性转换因子分别为0.012和0.014 mSv/mGy/cm。在B组中,使用修正转换因子提高了准确性,使用性别特异性转换因子消除了性别相关的残余误差。
全身PET/CT中CT部分的ED可通过将扫描仪得出的DLP乘以针对全身PET/CT优化的转换因子来评估。